224 related articles for article (PubMed ID: 38764032)
1. The Patient Activation Measure-13 (PAM-13) in an oncology patient population: psychometric properties and dimensionality evaluation.
Roesel I; Froehlich D; Joos S; Valentini J; Mauch H; Martus P
Health Qual Life Outcomes; 2024 May; 22(1):39. PubMed ID: 38764032
[TBL] [Abstract][Full Text] [Related]
2. Is the Patient Activation Measure a valid measure of osteoarthritis self-management attitudes and capabilities? Results of a Rasch analysis.
Eyles JP; Ferreira M; Mills K; Lucas BR; Robbins SR; Williams M; Lee H; Appleton S; Hunter DJ
Health Qual Life Outcomes; 2020 May; 18(1):121. PubMed ID: 32370751
[TBL] [Abstract][Full Text] [Related]
3. Measuring patient activation: the utility of the Patient Activation Measure administered in an interview setting.
Holter M; Avian A; Weger M; Strini S; Michelitsch M; Brenk-Franz K; Wedrich A; Berghold A
Qual Life Res; 2024 May; 33(5):1389-1400. PubMed ID: 38388807
[TBL] [Abstract][Full Text] [Related]
4. Validation of the patient activation measure in patients at discharge from hospitals and at distance from hospital care in Sweden.
Hellström A; Kassaye Tessma M; Flink M; Dahlgren A; Schildmeijer K; Ekstedt M
BMC Public Health; 2019 Dec; 19(1):1701. PubMed ID: 31856796
[TBL] [Abstract][Full Text] [Related]
5. The Chinese version of the Perceived Stress Questionnaire: development and validation amongst medical students and workers.
Meng R; Li J; Wang Z; Zhang D; Liu B; Luo Y; Hu Y; Yu C
Health Qual Life Outcomes; 2020 Mar; 18(1):70. PubMed ID: 32169070
[TBL] [Abstract][Full Text] [Related]
6. Psychometric assessment of the patient activation measure short form (PAM-13) in rural settings.
Hung M; Carter M; Hayden C; Dzierzon R; Morales J; Snow L; Butler J; Bateman K; Samore M
Qual Life Res; 2013 Apr; 22(3):521-9. PubMed ID: 22466721
[TBL] [Abstract][Full Text] [Related]
7. Adaptation to European Spanish and psychometric properties of the Patient Activation Measure 13 in patients with chronic diseases.
Moreno-Chico C; González-de Paz L; Monforte-Royo C; Arrighi E; Navarro-Rubio MD; Gallart Fernández-Puebla A
Fam Pract; 2017 Sep; 34(5):627-634. PubMed ID: 28379415
[TBL] [Abstract][Full Text] [Related]
8. Assessing self-management in patients with diabetes mellitus type 2 in Germany: validation of a German version of the Summary of Diabetes Self-Care Activities measure (SDSCA-G).
Kamradt M; Bozorgmehr K; Krisam J; Freund T; Kiel M; Qreini M; Flum E; Berger S; Besier W; Szecsenyi J; Ose D
Health Qual Life Outcomes; 2014 Dec; 12():185. PubMed ID: 25519204
[TBL] [Abstract][Full Text] [Related]
9. Psychometric properties of the SDM-Q-9 questionnaire for shared decision-making in multiple sclerosis: item response theory modelling and confirmatory factor analysis.
Ballesteros J; Moral E; Brieva L; Ruiz-Beato E; Prefasi D; Maurino J
Health Qual Life Outcomes; 2017 Apr; 15(1):79. PubMed ID: 28431587
[TBL] [Abstract][Full Text] [Related]
10. Psychometric Properties of the Patient Activation Measure in Family Caregivers of Patients With Chronic Illnesses.
Lin CY; Chung ML; Schuman DL; Biddle MJ; Mudd-Martin G; Miller JL; Hammash M; Schooler MP; Rayens MK; Feltner FJ; Moser DK
Nurs Res; 2023 Jul-Aug 01; 72(4):292-300. PubMed ID: 37011339
[TBL] [Abstract][Full Text] [Related]
11. Patient activation in Europe: an international comparison of psychometric properties and patients' scores on the short form Patient Activation Measure (PAM-13).
Rademakers J; Maindal HT; Steinsbekk A; Gensichen J; Brenk-Franz K; Hendriks M
BMC Health Serv Res; 2016 Oct; 16(1):570. PubMed ID: 27729079
[TBL] [Abstract][Full Text] [Related]
12. Psychometric evaluation of the German version of the Patient Activation Measure (PAM13).
Zill JM; Dwinger S; Kriston L; Rohenkohl A; Härter M; Dirmaier J
BMC Public Health; 2013 Oct; 13():1027. PubMed ID: 24172020
[TBL] [Abstract][Full Text] [Related]
13. Measuring patient activation in Italy: Translation, adaptation and validation of the Italian version of the patient activation measure 13 (PAM13-I).
Graffigna G; Barello S; Bonanomi A; Lozza E; Hibbard J
BMC Med Inform Decis Mak; 2015 Dec; 15():109. PubMed ID: 26699852
[TBL] [Abstract][Full Text] [Related]
14. Psychometric Evaluation of Chronic Patients Using the Persian Version of Patient Activation Measure (PAM).
Zakeri MA; Esmaeili Nadimi A; Bazmandegan G; Zakeri M; Dehghan M
Eval Health Prof; 2023 Jun; 46(2):115-126. PubMed ID: 35506588
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Chinese EORTC chronic lymphocytic leukaemia module - application of classical test theory and item response theory.
Dong D; Jin J; Oerlemans S; Yu S; Yang S; Zhu J; Xu RH
Health Qual Life Outcomes; 2020 Apr; 18(1):96. PubMed ID: 32264961
[TBL] [Abstract][Full Text] [Related]
16. Refinement and Validation of the Empowerment Audiology Questionnaire: Rasch Analysis and Traditional Psychometric Evaluation.
Bennett RJ; Larsson J; Gotowiec S; Ferguson M
Ear Hear; 2024 May-Jun 01; 45(3):583-599. PubMed ID: 38082487
[TBL] [Abstract][Full Text] [Related]
17. Development and psychometric properties of a scale for measuring internal participation from a patient and health care professional perspective.
Körner M; Wirtz MA
BMC Health Serv Res; 2013 Oct; 13():374. PubMed ID: 24083632
[TBL] [Abstract][Full Text] [Related]
18. Adaptation and validation of the German Patient Activation Measure for adolescents with chronic conditions in transitional care: PAM
Bomba F; Markwart H; Mühlan H; Menrath I; Ernst G; Thyen U; Schmidt S
Res Nurs Health; 2018 Feb; 41(1):78-87. PubMed ID: 29266283
[TBL] [Abstract][Full Text] [Related]
19. Translation and psychometric properties of the King's Sarcoidosis Questionnaire (KSQ) in German language.
Farin E; Heyduck K; Frye BC; Birring SS; Müller-Quernheim J; Schupp JC
Health Qual Life Outcomes; 2019 Apr; 17(1):62. PubMed ID: 30975148
[TBL] [Abstract][Full Text] [Related]
20. Stress of Conscience Questionnaire (SCQ): exploring dimensionality and psychometric properties at a tertiary hospital in Australia.
Jokwiro Y; Pascoe E; Edvardsson K; Rahman MA; McDonald E; Lood Q; Edvardsson D
BMC Psychol; 2020 Oct; 8(1):109. PubMed ID: 33081845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
